Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Debt / NOTE 4.000% 2/0
-
Market price (% of par)
-
94.81%
-
Total 13F principal
-
$272,240,014
-
Principal change
-
+$4,359,408
-
Total reported market value
-
$258,220,013
-
Number of holders
-
42
-
Value change
-
+$4,165,934
-
Number of buys
-
21
-
Number of sells
-
10
Institutional Holders of PDL BIOPHARMA INC - NOTE 4.000% 2/0 as of Q2 2015
As of 30 Jun 2015,
PDL BIOPHARMA INC - NOTE 4.000% 2/0 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$272,240,014
in principal (par value) of the bond.
The largest 10 bondholders included
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, CNH PARTNERS LLC, ADVENT CAPITAL MANAGEMENT /DE/, WOLVERINE ASSET MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, PIONEER INVESTMENT MANAGEMENT INC, OAKTREE CAPITAL MANAGEMENT LP, BASSO CAPITAL MANAGEMENT, L.P., WELLS FARGO & COMPANY/MN, and SILVERBACK ASSET MANAGEMENT LLC.
This page lists
42
institutional bondholders reporting positions
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.